Taille et prévisions du marché de Tecentriq (2021-2031), part mondiale et régionale, analyse des tendances et des opportunités de croissance

  • Report Code : TIPRE00016909
  • Category : Life Sciences
  • No. of Pages : 150
Acheter maintenant

INTRODUCTION SUR LE MARCHÉ Tecentriq est un type d'agent néoplasique sur ordonnance utilisé pour traiter le cancer de la vésicule biliaire, le cancer des voies urinaires, certains types de poumons et le cancer du sein. Tecentrique est utilisé si le cancer s’est propagé à d’autres parties du corps ou ne peut être retiré par chirurgie. Tecentriq est également utilisé si des problèmes surviennent lors de la chimiothérapie contenant du cisplatine. DYNAMIQUE DU MARCHÉ Les moteurs du marché les plus importants pour le marché de Tecentriq comprennent l'augmentation de l'incidence mondiale des cancers de la vessie, du poumon et du sein, ainsi que l'augmentation des investissements en recherche et développement de l'industrie pharmaceutique pour étudier de nouveaux candidats. Les effets secondaires possibles des médicaments et les coûts de traitement élevés pourraient avoir un impact négatif sur le marché au cours de la période de prévision. ÉTENDUE DU MARCHÉ Le « marché Tecentriq » est une étude spécialisée et approfondie de l'industrie pharmaceutique avec un accent particulier sur l'analyse des tendances du marché mondial. Le rapport vise à fournir un aperçu du marché de Tecentriq avec une segmentation détaillée du marché par type et par application. Le marché de Tecentriq devrait connaître une forte croissance au cours de la période de prévision. Le rapport fournit des statistiques clés sur l’état du marché des principaux acteurs du marché Tecentriq et présente les principales tendances et opportunités du marché. SEGMENTATION DU MARCHÉ Le marché de Tecentriq est segmenté en fonction du type et de l'application, en fonction du type dans lequel le marché est segmenté, 60 mg/ml et autres. Et en fonction des applications, le marché est segmenté en traitement du carcinome urothélial et du cancer du poumon non à petites cellules. Le rapport fournit un aperçu détaillé du secteur, y compris des informations qualitatives et quantitatives. Il fournit un aperçu et des prévisions du marché de Tecentriq en fonction de divers segments. Il fournit également la taille du marché et des estimations prévisionnelles pour les années 2021 à 2031 pour cinq grandes régions, à savoir : l’Amérique du Nord, l’Europe, l’Asie-Pacifique (APAC), le Moyen-Orient et l’Afrique (MEA) et l’Amérique du Sud et centrale. Le marché Tecentriq par région est ensuite divisé en pays et segments respectifs. Le rapport comprend des analyses et des prévisions pour 18 pays à travers le monde, ainsi que les tendances et opportunités actuelles dans la région. Le rapport analyse les facteurs affectant le marché de Tecentriq du côté de la demande et de l’offre et évalue en outre la dynamique du marché affectant le marché au cours de la période de prévision, c’est-à-dire les moteurs, les contraintes, les opportunités et les tendances futures. Le rapport fournit également une analyse complète des parasites pour les cinq régions, à savoir : Amérique du Nord, Europe, APAC, MEA et Amérique du Sud et centrale, après avoir évalué les facteurs politiques, économiques, sociaux et technologiques affectant le marché de Tecentriq dans ces régions. ACTEURS DU MARCHÉ Le rapport couvre les développements clés des stratégies de croissance organique et inorganique de Tecentriq Markets. Diverses entreprises se concentrent sur des stratégies de croissance organique telles que les lancements de produits, les approbations de produits et d'autres telles que les brevets et les événements. Les stratégies de croissance inorganique observées sur le marché comprenaient des acquisitions, des partenariats et des collaborations. Ces activités ont ouvert la voie à l'expansion des activités et de la clientèle des acteurs du marché. Les acteurs du marché Tecentriq devraient avoir des opportunités de croissance lucratives à l’avenir à mesure que la demande pour le marché Tecentriq augmente sur le marché mondial. Vous trouverez ci-dessous une liste de certaines des entreprises opérant sur le marché de Tecentriq. Le rapport comprend également les profils des principaux acteurs du marché Tecentriq ainsi que leur analyse SWOT et leurs stratégies de marché. En outre, le rapport se concentre sur les principaux acteurs du secteur avec des informations telles que les profils d'entreprise, les composants et les services proposés, les informations financières des trois dernières années et les développements clés des cinq dernières années.
    •  L'équipe de recherche et d'analyse dédiée de Genentech
Insight Partner est composée de professionnels expérimentés possédant une expertise statistique avancée et propose diverses options de personnalisation dans l'étude existante.
  • Analyse historique (2 ans), année de base, prévision (7 ans) avec TCAC
  • Analyse PEST et SWO
  • Taille du marché Valeur / Volume - Mondial, Régional, Pays
  • Industrie et paysage concurrentiel
  • Ensemble de données Excel
tecentriq-market-report-deliverables-img1
tecentriq-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Questions fréquemment posées


Which are the leading players operating in the Tecentriq Market?

The leading players of the market are: Abbott Laboratories, Amgen Inc., Biogen Idec, Bristol-Myers Squibb, Dendreon Corporation, Genentech Inc., Johnson & Johnson Services, Inc., Novo Nordisk, Schering-Plough Corporation, UCB Group

What are the deliverable formats of the Tecentriq Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

What are the future trends of the Tecentriq Market?

The future of the Tecentriq market looks promising with various emerging trends. First and foremost, the combination therapy in which Tecentriq is being used along with other drugs will increase its therapeutic use and market size. Advancements in personalized medicine and biomarker-driven therapies will likely play a very important role in optimizing the use of Tecentriq. Furthermore, increasing focus on patient-centric care and access to innovative therapies will help drive the Tecentriq market.

What is the expected CAGR of the Tecentriq Market?

Tecentriq Market is expected to grow at a CAGR of 11% between 2023-2031

What are the driving factors impacting the Tecentriq Market?

The rising incidence of diverse cancer types, especially lung cancer, bladder cancer, and melanoma, constitutes the prime market driver in the Tecentriq market. A large population base that is getting old coupled with changing lifestyle patterns and environmental conditions also results in high incidences of such diseases. Awareness regarding early diagnosis and treatment methods and further advances in research areas related to immunotherapy have led to demand for better therapy, like Tecentriq. In addition, encouraging government policies and cancer treatment re-imbursement policies are paving the way for Tecentriq to find adoption.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Genentech
tecentriq-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.